Skip to content

A Trial to Assess the Effect of High Nitrogen Intake in Critically Ill Patients

The Efficacy and Safety of High Nitrogen Intake in Critically Ill Patients: a Randomized and Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02106624
Enrollment
89
Registered
2014-04-08
Start date
2015-03-31
Completion date
2020-05-31
Last updated
2020-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill

Keywords

mechanical ventilation

Brief summary

The patients with sepsis are in high risk of malnutrition, which could contribute to infection, difficulty in weaning from ventilators. The investigators speculate whether nutrition therapy with high nitrogen could attenuate the malnutrition status and improve the outcome in these sepsis patients. In this prospective Randomized Controlled Trial, the investigators aim to compare high nitrogen intake with conventional nitrogen supply which were recommended in guidelines.

Interventions

OTHERnitrogen supply

Nitrogen supply could be administered through amino acid in parenteral nutrition, proteins in enteral nutrition.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* need mechanical ventilation for more than 2 days * mean blood pressure more than 60mmHg * predicted ICU stay more than 7 days * tolerance of parenteral or enteral nutrition

Exclusion criteria

* irreversible status of primary disease * any history of malnutrition before enrollment * history of steroid cortisol administration * severe liver dysfunction (Child-Pugh Score C) * pregnancy * refuse to enrollment * re-admission to ICU and has been enrolled during former admission to ICU

Design outcomes

Primary

MeasureTime frame
all cause mortality28 days

Secondary

MeasureTime frameDescription
ICU staypatients enrolled will be followed for length of ICU stay, an expected average of 6 weeks
infection incidence rate28 daysDetails of infection includes pneumonia, catheter-related blood stream infection, urinary tract infect, et al. Diagnosis of infection accords to symptoms, lab tests, imaging measurements and bacterial cultures.
Liver function and renal functionon 1st. day, 3rd. day, 7th. day, 14th. day, 21st. day, 28th. day after enrollmentLiver function is assessed through serum bilirubin and liver enzyme, renal function is assessed through serum urea nitrogen and creatinine.
duration on ventilatorspatients enrolled will be followed for the duration of mechanical ventilation, an expcected average of 4 weeks
serum concentration of albumin, pre albumin, retinaldehyde binding protein, transferrinon 7th. day , 14th. day, 21st. day, 28th. day after enrollment
change of body compositionon 7th.day, 14th.day, 21st.dat, 28th.day after enrollment
diameter of midpoint of musculus rectus femorison 28th. day or endpoint of the trialdiameter of the muscle is measured with percutaneous ultrasound

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026